Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

Abstract Patients with cirrhosis may show minimal hepatic encephalopathy (MHE), for which rifaximin is effective. Metabolic syndrome may be associated with cognitive impairment. Our aims were to evaluate the influence of metabolic syndrome features on response to rifaximin for neurological and infla...

Full description

Bibliographic Details
Main Authors: María-Pilar Ballester, Juan-José Gallego, Alessandra Fiorillo, Franc Casanova-Ferrer, Carla Giménez-Garzó, Desamparados Escudero-García, Joan Tosca, María-Pilar Ríos, Cristina Montón, Lucía Durbán, José Ballester, Salvador Benlloch, Amparo Urios, Teresa San-Miguel, Elena Kosenko, Miguel-Ángel Serra, Vicente Felipo, Carmina Montoliu
Format: Article
Language:English
Published: Nature Portfolio 2022-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-06416-z

Internet

https://doi.org/10.1038/s41598-022-06416-z

Similar Items